Epinephrine is a catecholamine hormone produced primarily by chromaffin cells of the adrenal medulla. Its secretion is stimulated by sympathetic preganglionic fibers during stress and contributes to the fight-or-flight response by increasing cardiac activity, redistributing blood flow, dilating the airways, and mobilizing glucose and fatty acids.
Epinephrine, also called adrenaline, is a catecholamine produced and secreted primarily by chromaffin cells of the adrenal medulla. It functions predominantly as a circulating hormone and is an important component of the body's rapid response to physiological stress.
The adrenal medulla forms the central portion of the adrenal gland and functions as a specialized neuroendocrine component of the sympathetic nervous system. Its chromaffin cells are functionally related to postganglionic sympathetic neurons. Instead of extending axons to individual target organs, these cells release catecholamines directly into the bloodstream.
Epinephrine acts through alpha and beta adrenergic receptors distributed throughout the body. Its effects include increased heart rate and myocardial contractility, redistribution of blood flow, bronchodilation, stimulation of hepatic glucose production, and mobilization of stored metabolic fuels. Together, these responses help prepare the body for rapid increases in physical and metabolic demand.
Epinephrine is produced primarily in the adrenal medulla, the central region of each adrenal gland.
The adrenal medulla is surrounded by the adrenal cortex and contains clusters and cords of catecholamine-secreting chromaffin cells associated with a rich vascular network.
The adrenal medulla is derived embryologically from neural crest cells. This developmental origin distinguishes it from the adrenal cortex, which develops from mesoderm.
Neural crest-derived cells migrate into the developing adrenal gland and differentiate into chromaffin cells.
Chromaffin cells are specialized neuroendocrine cells responsible for synthesis, storage, and secretion of catecholamines.
They are often described as modified postganglionic sympathetic neurons because they receive direct input from sympathetic preganglionic fibers but release their chemical products into the circulation rather than through conventional neuronal terminals.
Catecholamines are stored within membrane-bound secretory vesicles known as chromaffin granules.
Following appropriate neural stimulation, these vesicles undergo exocytosis and release their contents into the extracellular space and subsequently into the adrenal medullary circulation.
| Catecholamine | Major Feature |
|---|---|
| Epinephrine | Major catecholamine secreted by the adrenal medulla |
| Norepinephrine | Also secreted by chromaffin cells and is a major sympathetic neurotransmitter elsewhere in the body |
| Dopamine | Precursor in catecholamine synthesis and present in smaller quantities |
Epinephrine is synthesized from the amino acid tyrosine through a sequence of enzymatic reactions.
The major pathway is:
Tyrosine → L-DOPA → Dopamine → Norepinephrine → Epinephrine
Tyrosine is the amino acid precursor for catecholamine synthesis.
Chromaffin cells take up tyrosine and convert it through a series of enzymatic reactions into dopamine, norepinephrine, and ultimately epinephrine.
Tyrosine hydroxylase converts tyrosine into L-3,4-dihydroxyphenylalanine (L-DOPA).
This reaction is the rate-limiting step in catecholamine biosynthesis.
L-DOPA is converted into dopamine by aromatic L-amino acid decarboxylase, commonly called DOPA decarboxylase.
Dopamine is transported into secretory vesicles, where dopamine beta-hydroxylase converts dopamine into norepinephrine.
The final conversion of norepinephrine into epinephrine is catalyzed by phenylethanolamine N-methyltransferase (PNMT).
PNMT is highly expressed in epinephrine-producing chromaffin cells of the adrenal medulla.
| Substrate | Enzyme | Product |
|---|---|---|
| Tyrosine | Tyrosine hydroxylase | L-DOPA |
| L-DOPA | DOPA decarboxylase | Dopamine |
| Dopamine | Dopamine beta-hydroxylase | Norepinephrine |
| Norepinephrine | PNMT | Epinephrine |
The anatomical relationship between the adrenal cortex and medulla contributes directly to epinephrine synthesis.
Blood from cortical sinusoids passes toward the medulla, exposing medullary chromaffin cells to high local concentrations of glucocorticoids produced by the cortex.
Cortisol reaching the adrenal medulla from the cortex promotes expression of PNMT.
This supports conversion of norepinephrine into epinephrine and represents an important functional interaction between the adrenal cortex and adrenal medulla.
The adrenal vascular arrangement allows blood that has passed through the cortex to enter medullary vessels.
As a result, chromaffin cells can be exposed to concentrations of cortisol considerably higher than those found in the general systemic circulation.
The adrenal medulla receives direct innervation from sympathetic preganglionic neurons.
This arrangement differs from the typical sympathetic pathway, in which a preganglionic neuron synapses with a postganglionic neuron within a sympathetic ganglion.
Preganglionic sympathetic fibers reach the adrenal medulla primarily through thoracic splanchnic nerves after passing through sympathetic ganglia without synapsing.
They terminate directly on chromaffin cells.
Sympathetic preganglionic fibers release acetylcholine onto chromaffin cells.
Acetylcholine binds to neuronal nicotinic receptors on the chromaffin cell membrane.
Activation of nicotinic acetylcholine receptors depolarizes chromaffin cells and promotes calcium-dependent exocytosis of catecholamine-containing secretory granules.
Once released from chromaffin cells, epinephrine enters the extensive sinusoidal circulation of the adrenal medulla and is carried into the systemic circulation.
Because epinephrine circulates in blood, it can act simultaneously on adrenergic receptors in multiple organs.
The adrenal medulla can be viewed as a specialized sympathetic neuroendocrine organ.
| Typical Sympathetic Pathway | Adrenal Medullary Pathway |
|---|---|
| Preganglionic neuron | Preganglionic neuron |
| Sympathetic ganglion | Chromaffin cell |
| Postganglionic neuron | No conventional postganglionic axon |
| Neurotransmitter released near target | Catecholamine released into bloodstream |
Epinephrine secretion increases during conditions that activate the sympathetic nervous system and adrenal medulla.
Important stimuli can include:
Epinephrine is an important mediator of the rapid physiological response traditionally described as the fight-or-flight response.
Its actions increase cardiovascular performance, improve airflow, redistribute circulation, and rapidly mobilize energy substrates.
Epinephrine exerts its effects through adrenergic receptors, which are G protein-coupled receptors expressed in numerous tissues.
The major receptor families relevant to epinephrine include:
α1 receptors are expressed prominently in vascular smooth muscle in many vascular beds.
Activation commonly produces smooth muscle contraction and vasoconstriction.
α2 receptors have important presynaptic and postsynaptic functions.
Presynaptic α2 receptor activation can inhibit further norepinephrine release from sympathetic nerve terminals.
β1 receptors are particularly important in the heart.
Activation increases heart rate, myocardial contractility, and conduction through components of the cardiac conduction system.
β2 receptors are important in bronchial smooth muscle and selected vascular beds, particularly vessels supplying skeletal muscle.
Activation generally promotes smooth muscle relaxation.
β3 receptors participate in metabolic regulation, particularly within adipose tissue.
Activation can promote mobilization of stored lipid.
| Receptor | Representative Effect |
|---|---|
| α1 | Vascular smooth muscle contraction |
| α2 | Modulation of neurotransmitter release and metabolic functions |
| β1 | Increased cardiac rate and contractility |
| β2 | Bronchodilation and smooth muscle relaxation in selected vascular beds |
| β3 | Metabolic effects including lipolysis |
Epinephrine has powerful cardiovascular actions resulting from simultaneous effects on the heart and blood vessels.
The overall response depends on circulating epinephrine concentration and the distribution and sensitivity of adrenergic receptor subtypes.
Activation of cardiac β1 receptors increases the firing rate of the sinoatrial node.
This produces a positive chronotropic effect and increases heart rate.
Epinephrine increases myocardial contractility through β1 receptor activation.
This positive inotropic effect increases the force of ventricular contraction.
β1 receptor stimulation increases conduction through the atrioventricular node and other components of the cardiac conduction system.
This is described as a positive dromotropic effect.
By increasing heart rate and stroke volume, epinephrine can increase cardiac output.
This helps deliver oxygen and metabolic substrates to tissues during acute physiological demand.
Epinephrine can produce either vasoconstriction or vasodilation depending on the vascular bed, receptor subtype, and circulating concentration.
Activation of α1 receptors produces vasoconstriction in many vessels, particularly in the skin, mucosa, and portions of the visceral circulation.
β2 receptor activation can relax vascular smooth muscle, particularly in vessels supplying skeletal muscle.
Epinephrine has substantial β2 activity and can therefore promote increased blood flow to skeletal muscle under appropriate conditions.
Epinephrine commonly increases systolic arterial pressure through increased cardiac output.
Its effect on diastolic pressure is more variable because β2-mediated vasodilation can reduce peripheral vascular resistance while α-mediated vasoconstriction acts in the opposite direction.
| Target | Major Effect | Principal Receptor |
|---|---|---|
| SA node | Increased heart rate | β1 |
| Myocardium | Increased contractility | β1 |
| AV conduction | Increased conduction | β1 |
| Many systemic vessels | Vasoconstriction | α1 |
| Skeletal muscle vessels | Potential vasodilation | β2 |
Epinephrine has important effects on the respiratory system, particularly through activation of β2 adrenergic receptors.
β2 receptor activation relaxes bronchial smooth muscle and produces bronchodilation.
This decreases airway resistance and facilitates airflow during acute sympathetic activation.
Epinephrine rapidly increases the availability of metabolic fuels.
Its metabolic effects involve the liver, skeletal muscle, adipose tissue, and endocrine pancreas.
Epinephrine stimulates glycogenolysis, the breakdown of glycogen.
In the liver, glycogen breakdown contributes to increased glucose availability in the circulation.
Epinephrine increases hepatic glucose output through effects on glycogen metabolism and gluconeogenic pathways.
This helps maintain glucose availability during acute stress and exercise.
Epinephrine stimulates glycogen breakdown in skeletal muscle.
Muscle glycogen provides substrate for local energy production rather than directly releasing free glucose into the bloodstream.
Epinephrine can support increased hepatic gluconeogenesis, particularly during physiological stress and hypoglycemia.
Epinephrine can suppress insulin secretion through α2 adrenergic receptor activity on pancreatic beta cells.
This helps preserve circulating glucose during acute stress.
Catecholaminergic stimulation can promote glucagon secretion, supporting hepatic glucose production during stress and hypoglycemia.
Epinephrine promotes lipolysis in adipose tissue through adrenergic signaling.
Stored triglycerides are broken down, increasing the availability of fatty acids as metabolic fuel.
| Process | Effect of Epinephrine |
|---|---|
| Hepatic glycogenolysis | Increased |
| Muscle glycogenolysis | Increased |
| Hepatic glucose output | Increased |
| Lipolysis | Increased |
| Insulin secretion | Can decrease through α2 signaling |
| Glucagon secretion | Can increase |
Epinephrine is an important counter-regulatory hormone during hypoglycemia.
When blood glucose falls, sympathoadrenal activation increases epinephrine secretion, which promotes hepatic glucose production and limits insulin-mediated storage of metabolic fuels.
Epinephrine secretion can increase during exercise, particularly as exercise intensity rises.
Its cardiovascular and metabolic effects help support increased skeletal muscle activity by increasing cardiac performance and mobilizing metabolic substrates.
Sympathetic adrenergic activity contributes to contraction of the radial muscle of the iris.
Activation of α1 receptors produces pupillary dilation, or mydriasis.
Sympathoadrenal activation generally reduces gastrointestinal motility and alters gastrointestinal smooth muscle and sphincter activity.
These effects help redirect physiological resources away from digestion during acute stress.
Adrenergic receptors influence smooth muscle in the urinary tract.
Sympathetic activation can promote relaxation of the detrusor and contraction of portions of the bladder outlet, supporting urine storage during acute sympathetic activity.
Although epinephrine is chemically related to sympathetic neurotransmitters, adrenal medullary epinephrine functions primarily as a hormone.
It is released into blood and reaches target tissues through the circulation.
Epinephrine and norepinephrine are closely related catecholamines but differ in their principal sources and receptor profiles.
| Feature | Epinephrine | Norepinephrine |
|---|---|---|
| Major endocrine source | Adrenal medulla | Adrenal medulla produces a smaller proportion |
| Major neural role | Limited compared with norepinephrine | Major neurotransmitter of most postganglionic sympathetic neurons |
| β2 activity | Prominent | Relatively weak |
| Typical vascular effect | Mixed vasoconstriction and vasodilation depending on receptor distribution | Predominantly vasoconstriction in many vascular beds |
Epinephrine and cortisol are both involved in physiological responses to stress, but they originate from different regions of the adrenal gland and act through different mechanisms.
| Feature | Epinephrine | Cortisol |
|---|---|---|
| Adrenal region | Medulla | Cortex, primarily zona fasciculata |
| Hormone type | Catecholamine | Steroid hormone |
| Primary control | Sympathetic preganglionic neurons | ACTH |
| Receptor type | Cell-surface adrenergic receptors | Intracellular glucocorticoid receptor |
| Response speed | Rapid | Many effects develop more gradually |
Epinephrine has a relatively short plasma half-life because it is rapidly metabolized and removed from the circulation.
This allows the sympathoadrenal system to produce rapid responses that can also decline relatively quickly when stimulation ends.
Epinephrine is metabolized primarily through the actions of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO).
These enzymes participate in the conversion of catecholamines into inactive metabolites that can be eliminated from the body.
Epinephrine can be metabolized by COMT to form metanephrine.
Measurement of metanephrines is clinically useful because catecholamine-producing tumors can continuously generate these metabolites even when catecholamine secretion itself is episodic.
Vanillylmandelic acid (VMA) is an end product of catecholamine metabolism that can be measured in urine.
Modern evaluation of catecholamine-producing tumors commonly emphasizes plasma free or urinary fractionated metanephrines.
| Component | Role |
|---|---|
| COMT | Catecholamine methylation |
| MAO | Oxidative metabolism of monoamines |
| Metanephrine | Important metabolite of epinephrine |
| VMA | Urinary end product of catecholamine metabolism |
Pheochromocytoma is a catecholamine-producing tumor arising from chromaffin cells, most commonly within the adrenal medulla.
These tumors can secrete norepinephrine, epinephrine, dopamine, or combinations of catecholamines.
Excessive catecholamine secretion can produce manifestations including:
Paragangliomas are tumors arising from paraganglionic tissue outside the adrenal gland.
Some sympathetic paragangliomas produce catecholamines and can cause physiological effects similar to those of adrenal pheochromocytomas.
Biochemical evaluation of suspected catecholamine-producing tumors commonly includes measurement of plasma free metanephrines or urinary fractionated metanephrines.
These metabolites can provide evidence of excessive catecholamine production.
Epinephrine is also used pharmacologically because its adrenergic receptor effects can rapidly influence airway caliber, vascular tone, and cardiac activity.
Epinephrine is a critical treatment for anaphylaxis.
Its α1-mediated vasoconstrictor effects help counteract vasodilation and vascular leakage, while β2 receptor activation promotes bronchodilation and β1 receptor activation supports cardiac function.
Epinephrine is used during selected cardiac arrest resuscitation protocols.
Its α-adrenergic vasoconstrictor effects can increase vascular resistance and help improve perfusion pressure during cardiopulmonary resuscitation.
Epinephrine can be combined with selected local anesthetic preparations.
Local vasoconstriction can reduce systemic absorption from the injection site and prolong the local effect of the anesthetic in appropriate clinical settings.
| Organ or Tissue | Important Receptor | Representative Effect |
|---|---|---|
| Heart | β1 | Increased rate and contractility |
| Bronchi | β2 | Bronchodilation |
| Skin vessels | α1 | Vasoconstriction |
| Skeletal muscle vessels | β2 | Vasodilation |
| Pancreatic beta cells | α2 | Reduced insulin secretion |
| Adipose tissue | β receptors | Increased lipolysis |
The physiological effects of epinephrine are coordinated rather than isolated. Increased cardiac output improves systemic blood delivery, bronchodilation facilitates ventilation, vascular responses redistribute blood flow, and metabolic effects increase the availability of glucose and fatty acids.
This integrated response enables rapid adaptation to situations requiring increased muscular, cardiovascular, and metabolic activity.
The close functional relationship between the adrenal medulla and sympathetic nervous system is often described collectively as the sympathoadrenal system.
Sympathetic nerve terminals can produce highly localized responses, while circulating adrenal catecholamines provide a more widespread hormonal component of sympathetic activation.
| Feature | Sympathetic Nerve Terminal | Adrenal Medulla |
|---|---|---|
| Major secretory cell | Postganglionic sympathetic neuron | Chromaffin cell |
| Major catecholamine | Norepinephrine in most pathways | Predominantly epinephrine |
| Route | Released near target tissue | Released into circulation |
| Distribution | Relatively localized | Systemic |
The neural crest origin of chromaffin cells explains their close developmental and functional relationship to sympathetic neurons.
During development, neural crest cells associated with the sympathetic lineage migrate into the adrenal gland and differentiate into endocrine chromaffin cells under the influence of the adrenal environment.
Chromaffin cells are arranged in clusters or cords surrounding sinusoidal vessels within the adrenal medulla.
The extensive vascular supply facilitates rapid entry of secreted catecholamines into the circulation.
The term chromaffin originates from the historical observation that catecholamine-containing cells develop a brown coloration when exposed to chromium salts because of oxidation of stored catecholamines.
The adrenal glands possess an abundant arterial supply and specialized sinusoidal circulation.
This vascular arrangement supports both delivery of cortical hormones to the medulla and rapid transport of medullary catecholamines into the systemic circulation.
Blood from the adrenal medulla ultimately drains toward the central adrenal vein.
The right adrenal vein typically drains directly into the inferior vena cava, while the left adrenal vein usually drains into the left renal vein.
Unlike deficiencies of essential adrenal cortical hormones such as cortisol or aldosterone, isolated loss of adrenal epinephrine production does not usually produce a comparable endocrine deficiency syndrome.
Sympathetic neurons and other counter-regulatory mechanisms can compensate for many functions ordinarily supported by adrenal catecholamines.
Epinephrine and cortisol participate in different but complementary components of the stress response.
Epinephrine produces rapid cardiovascular, respiratory, and metabolic changes, while cortisol supports longer-lasting metabolic adaptation and modifies cardiovascular and immune responses.
| Feature | Key Point |
|---|---|
| Alternative name | Adrenaline |
| Hormone class | Catecholamine |
| Primary source | Chromaffin cells of adrenal medulla |
| Embryological origin of secretory cells | Neural crest |
| Precursor | Tyrosine |
| Immediate precursor | Norepinephrine |
| Final synthesis enzyme | PNMT |
| Major stimulus | Preganglionic sympathetic activity |
| Neurotransmitter stimulating chromaffin cells | Acetylcholine |
| Chromaffin cell receptor | Nicotinic acetylcholine receptor |
| Target receptors | Alpha and beta adrenergic receptors |
| Major cardiac receptor | β1 |
| Major bronchial receptor | β2 |
| Major metabolic role | Rapid mobilization of glucose and fatty acids |
| Condition or Application | Relationship to Epinephrine |
|---|---|
| Pheochromocytoma | Adrenal chromaffin tumor that may produce excessive catecholamines |
| Paraganglioma | Extra-adrenal paraganglionic tumor, some of which produce catecholamines |
| Anaphylaxis | Epinephrine provides α1, β1, and β2 effects that counter major physiological abnormalities |
| Cardiac arrest | Used in selected resuscitation protocols |
| Hypoglycemia | Functions as a counter-regulatory hormone |
Epinephrine demonstrates the close anatomical and functional relationship between the adrenal medulla and sympathetic nervous system. Neural crest-derived chromaffin cells receive direct cholinergic input from sympathetic preganglionic neurons and translate that neural signal into widespread endocrine secretion.
Its synthesis also illustrates the integration of the adrenal cortex and medulla. Cortisol delivered from the cortex to the medulla promotes PNMT expression and thereby supports conversion of norepinephrine into epinephrine. The specialized adrenal circulation therefore contributes directly to medullary endocrine function.
Once released into the bloodstream, epinephrine acts on adrenergic receptors throughout the body. Its coordinated cardiovascular, respiratory, and metabolic effects increase cardiac performance, facilitate airflow, redistribute blood flow, and mobilize energy substrates. These properties make epinephrine a central hormone of the acute sympathoadrenal response and explain its major clinical importance in conditions such as anaphylaxis and catecholamine-producing tumors.